Pharmacology, Toxicology and Pharmaceutical Science
Acute Hepatitis
11%
Antibody Conjugate
18%
Bioavailability
15%
Blood-Brain Barrier
5%
Bloodstream Infection
46%
Breast Cancer
9%
Candida
46%
Candida albicans
35%
Candida parapsilosis
23%
Candida tropicalis
11%
Candidemia
46%
Candidiasis
11%
Carbon Nanotube
18%
Clinical Trial
9%
Controlled Release
9%
Cytotoxicity
9%
Dendrimer
18%
Electric Shock
15%
Enzyme-Linked Immunosorbent Assay
5%
Glioblastoma
46%
Growth Factor
5%
Hematologic Disease
5%
Hepatitis E Virus
93%
Immunocompromised Patient
11%
Immunoglobulin G
5%
Immunoglobulin M Antibody
11%
Infection
29%
Malignant Neoplasm
33%
Mammalian Target of Rapamycin
46%
Mammalian Target of Rapamycin Complex 1
7%
Mating Hormone Alpha Factor
46%
Median Survival Time
11%
microRNA
46%
Mortality Rate
23%
Nanocarrier
18%
Nanomedicine
5%
Nanoparticle
28%
Natural Product
9%
Passive Targeting
18%
Pentetrazole
15%
Phosphatidylinositol 3 Kinase
46%
Piracetam
46%
Prevalence
58%
Prospective Study
11%
Resistance to Antifungal Agent
23%
Seroprevalence
11%
Tonic Clonic Seizure
46%
Triple Negative Breast Cancer
46%
Virus Infection
46%
Virus RNA
11%
Immunology and Microbiology
Antifungal Resistance
13%
Antifungal Susceptibility
13%
Blood Level
9%
Blood Plasma
18%
Blood Product
11%
Blood Transfusion
11%
Cancer Immunotherapy
46%
Candida
46%
Candida albicans
19%
Candida krusei
13%
Candida parapsilosis
13%
Candida tropicalis
6%
Dipeptidyl Peptidase IV
93%
ELISA
21%
Enterobacterales
93%
Etest
15%
Immune Escape
23%
Immunocompromised Patient
11%
Immunoglobulin G
11%
Immunoglobulin M Antibody
23%
Immunotherapy
23%
Infection
84%
Microbiology
6%
Middle East Respiratory Syndrome Coronavirus
93%
Minimum Inhibitory Concentration
14%
Mortality Rate
13%
Multiplex Polymerase Chain Reaction
15%
Prevalence
100%
Reverse Transcription Polymerase Chain Reaction
11%
Ribonucleic Acid
23%
Seroprevalence
23%
Single Nucleotide Polymorphism
18%
Susceptibility
23%
Viral Disease
93%
Virus
18%
Medicine and Dentistry
Acetylcholinesterase
18%
All Cause Mortality
15%
Alzheimer's Disease
93%
Anemia
15%
Antibiogram
15%
Antibiotic Therapy
15%
Bloodstream Infection
15%
Ceftazidime
15%
Cognitive Decline
18%
Cohort Study
15%
Cystic Fibrosis
46%
Dextro Aspartic Acid
18%
Dietary Pattern
18%
Hospital Infection
15%
Infection
46%
Infection Prevention
15%
Intensive Care Unit
15%
Leukocytosis
15%
Levofloxacin
15%
Lifestyle Modification
18%
Logistic Regression Analysis
15%
Neurodegeneration
37%
Neurotransmitter
93%
Pathology of Alzheimer's Disease
18%
Primary Outcome
15%
Receptor
18%
Recurrent Disease
15%
Stenotrophomonas maltophilia
46%
Targeted Therapy
18%
Tau Protein
18%
Thrombocytopenia
15%
Trimethoprim/Sulfamethoxazole
15%